# A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat

> **NCT03095521** · PHASE3 · COMPLETED · sponsor: **Sandoz** · enrollment: 228 (actual)

## Conditions studied

- Sore Throat

## Interventions

- **DRUG:** Angal, lozenges [menthol],
- **DRUG:** ANTI-ANGIN® FORMULA

## Key facts

- **NCT ID:** NCT03095521
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-22
- **Primary completion:** 2017-05-07
- **Final completion:** 2017-05-07
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03095521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03095521, "A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03095521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*